Shengli Meng.jpg
Shengli Meng 孟胜利

Deputy Director, Wuhan Institute of Biological Products, Research Centre, Sinopharm Group

国药集团中国生物武汉生物制品研究所副主任

Mr. Shengli Meng was Doctor of Immunology at Wuhan Institute of Biological Products from 2004-2010.  From 2010 to now, he has been the Deputy Director of Wuhan Institute of Biological Products.

 

He participated in the development of "2019-NCOV inactivated vaccine”.  Publications include articles and books for international and domestic magazines.

 

Mr. Meng is also an editorial board member of international Journal of Biological Products; evaluation expert of Wuhan Science and Technology Bureau; expert of Chinese biological quality management; and has more than 10 years of experience in virus and vaccine related research. He is also familiar with the development progress and technical path of domestic vaccine.

2004-2010年,武汉生物制品研究所,免疫学博士

2010-至今,一直任职于武汉生物制品研究所,目前为研究所副主任

重点研究成果:参与开发 “2019-nCov灭活疫苗”

著作包括多篇国际国内杂志的文章和书籍

国际生物制品学杂志编委、武汉市科技局评审专家、中国生物质量管理专家

10年以上的病毒、疫苗相关研究经验,可以聊国内疫苗的研发进展,技术路径等。

Copyright © 2020 Nomura

This website is the sole property of Nomura. No part of this website may be reproduced in any form of by any means - electronic, mechanical, photocopying, recording or otherwise - without the prior written permission of Nomura.